Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
NKTX250516C1500
- 0.44
- 0.000.00%
15min DelayClose Apr 30 16:00 ET
0.00High0.00Low
0.44Open0.44Pre Close0 Volume1 Open Interest1.50Strike Price0.00Turnover265.15%IV-8.49%PremiumMay 16, 2025Expiry Date0.62Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8182Delta0.2273Gamma2.74Leverage Ratio-0.0101Theta0.0004Rho2.24Eff Leverage0.0012Vega
Nkarta Newsroom
Needham Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11
Nkarta Price Target Maintained With a $11.00/Share by Needham
Nkarta Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Nkarta (NKTX) and Regeneron (REGN)
William Blair Maintains Nkarta(NKTX.US) With Buy Rating
Needham Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11
Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR), Perspective Therapeutics (CATX) and Nkarta (NKTX)
Nkarta Is Maintained at Buy by Stifel
Nkarta Price Target Maintained With a $11.00/Share by Needham
Nkarta Analyst Ratings
TD Cowen Maintains Nkarta(NKTX.US) With Buy Rating
TD Cowen Keeps Their Buy Rating on Nkarta (NKTX)
Leerink Partners Maintains Nkarta(NKTX.US) With Buy Rating, Announces Target Price $7
Nkarta (NKTX) Gets a Buy From Leerink Partners
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)
Nkarta Is Maintained at Outperform by Mizuho
Nkarta Analyst Ratings
A Quick Look at Today's Ratings for Nkarta(NKTX.US), With a Forecast Between $11 to $18
Needham Maintains Nkarta(NKTX.US) With Buy Rating, Cuts Target Price to $11
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Veeva Systems (VEEV)
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now